492 related articles for article (PubMed ID: 33456757)
1. Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.
Tampouratzi E; Kanni T; Katsantonis J; Douvali T
F1000Res; 2019; 8():2002. PubMed ID: 33456757
[TBL] [Abstract][Full Text] [Related]
2. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.
Berman HS; Villa NM; Shi VY; Hsiao JL
J Dermatolog Treat; 2021 Mar; 32(2):261-263. PubMed ID: 31389737
[TBL] [Abstract][Full Text] [Related]
3. Certolizumab pegol as an alternative treatment in patients with coexisting hidradenitis suppurativa and other inflammatory immune-mediated diseases: Report of two cases.
Melgosa Ramos FJ; García Ruiz R; Mateu Puchades A
Dermatol Ther; 2022 May; 35(5):e15401. PubMed ID: 35199899
[No Abstract] [Full Text] [Related]
4. Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases.
Yoshida Y; Oyama N; Iino S; Shimizu C; Hasegawa M
J Dermatol; 2021 Jun; 48(6):916-920. PubMed ID: 33609416
[TBL] [Abstract][Full Text] [Related]
5. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
Yen CF; Huang YH; Chi CC
Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis Onset during Anti-TNF Treatment for Hidradenitis Suppurativa: Successful Remission of Both Conditions with Secukinumab.
Kontochristopoulos G; Kanni T; Marnelakis I; Agiasofitou E; Liakou A; Rigopoulos D
Skinmed; 2023; 21(1):57-58. PubMed ID: 36987833
[No Abstract] [Full Text] [Related]
7. Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa.
Repetto F; Burzi L; Ramondetta A; Rozzo G; Licciardello M; Ribero S; Quaglino P; Dapavo P
Int J Dermatol; 2022 May; 61(5):e182-e184. PubMed ID: 34270087
[No Abstract] [Full Text] [Related]
8. Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real-life experience.
Esme P; Akoglu G; Dalkıran CD; Caliskan E
Dermatol Ther; 2022 Nov; 35(11):e15782. PubMed ID: 35996992
[TBL] [Abstract][Full Text] [Related]
9. Ixekizumab in hidradenitis suppurativa in a psoriatic patient.
Odorici G; Pellacani G; Conti A
G Ital Dermatol Venereol; 2020 Dec; 155(6):788-789. PubMed ID: 30636397
[No Abstract] [Full Text] [Related]
10. Certolizumab to treat hidradenitis suppurativa.
Shadid A; Alobaida S; Binamer Y
Dermatol Reports; 2023 Jun; 15(2):9566. PubMed ID: 37397399
[TBL] [Abstract][Full Text] [Related]
11. Certolizumab pegol for hidradenitis suppurativa: Case report and literature review.
Holm JG; Jørgensen AR; Yao Y; Thomsen SF
Dermatol Ther; 2020 Nov; 33(6):e14494. PubMed ID: 33135826
[No Abstract] [Full Text] [Related]
12. One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast.
Lanna C; Mazzilli S; Zangrilli A; Bianchi L; Campione E
Dermatol Ther; 2019 Nov; 32(6):e13089. PubMed ID: 31577864
[TBL] [Abstract][Full Text] [Related]
13. The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study.
Frew JW; Navrazhina K; Grand D; Sullivan-Whalen M; Gilleaudeau P; Garcet S; Ungar J; Krueger JG
J Am Acad Dermatol; 2020 Nov; 83(5):1341-1348. PubMed ID: 32416208
[TBL] [Abstract][Full Text] [Related]
14. Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.
Baerveldt EM; Kappen JH; Thio HB; van Laar JA; van Hagen PM; Prens EP
Ann Rheum Dis; 2013 Apr; 72(4):626-7. PubMed ID: 23148307
[No Abstract] [Full Text] [Related]
15. Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy.
Wohlmuth-Wieser I; Alhusayen R
Int J Dermatol; 2021 Apr; 60(4):e140-e141. PubMed ID: 33247833
[No Abstract] [Full Text] [Related]
16. Management of recalcitrant hidradenitis suppurativa with ustekinumab.
Sharon VR; Garcia MS; Bagheri S; Goodarzi H; Yang C; Ono Y; Maverakis E
Acta Derm Venereol; 2012 May; 92(3):320-1. PubMed ID: 22101775
[No Abstract] [Full Text] [Related]
17. Brodalumab for severe hidradenitis suppurativa: a case of clinico-radiologic improvement and literature review.
Vagnozzi E; Bruni M; Esposito M; Fargnoli MC
J Dermatolog Treat; 2023 Dec; 34(1):2270091. PubMed ID: 37842732
[TBL] [Abstract][Full Text] [Related]
18. Rapid Response to Certolizumab Pegol in Hidradenitis Suppurativa: A Case Report.
Esme P; Akoglu G; Caliskan E
Skin Appendage Disord; 2021 Jan; 7(1):58-61. PubMed ID: 33614722
[TBL] [Abstract][Full Text] [Related]
19. A case of moderate hidradenitis suppurativa and psoriasis successfully treated with risankizumab.
Licata G; Gambardella A; Buononato D; De Rosa A; Calabrese G; Pellerone S; Argenziano G
Int J Dermatol; 2022 Apr; 61(4):e126-e129. PubMed ID: 34151438
[No Abstract] [Full Text] [Related]
20. Moderate to severe hidradenitis suppurativa treated with biological therapies.
Chinniah N; Cains GD
Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
